ARTICLE | Clinical News
Patanase olopatadine hydrochloride regulatory update
April 21, 2008 7:00 AM UTC
FDA approved an NDA from Alcon for Patanase olopatadine nasal spray to treat seasonal allergic rhinitis in patients 12 years and older. The company plans to launch the twice-daily intranasal formulati...